Form 4: Medifast CEO Daniel Chard Reports Stock Disposals for Tax Obligations

Daniel Chard, Chairman & CEO of Medifast, Inc., reports disposals of common stock to cover withholding tax obligations upon vesting of restricted stock units.

Summary

• On March 15, 2024, Daniel R. Chard, Chairman & CEO of Medifast, Inc., disposed of shares of common stock to cover withholding tax obligations.
• The disposals were executed at a price of $36.61 per share.
• A total of 608, 942, and 1,859 shares were disposed of in separate transactions.
• Following these transactions, Mr. Chard directly owns 99,821 shares of Medifast common stock.
• Additionally, 108,598.352 shares are indirectly owned through The Dan and Allyson Family Irrevocable Trust, for which Mr. Chard is the Settlor and Investment Trustee.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by an insider. It doesn't inherently convey positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The stock disposal may have a minor impact on shareholders due to the increased supply of shares in the market, but it is unlikely to be significant given the relatively small number of shares involved.

Key Dates